We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
(+19%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
14.77%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$82.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$78.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$57.7M |
| 4 |
Teradyne
TER
|
+$56.1M |
| 5 |
AbbVie
ABBV
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.1M |
| 2 |
Zimmer Biomet
ZBH
|
+$56.1M |
| 3 |
NVIDIA
NVDA
|
+$55.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$54.7M |
| 5 |
eBay
EBAY
|
+$40.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.02% |
| 3 | Communication Services | 8.75% |
| 4 | Financials | 5.58% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bristol-Myers Squibb
BMY
$132B
| $26.4M | 0.49% |
395,570
-211,261
| -35% | -$13.8M |
|
52
Mastercard
MA
$510B
| $25.8M | 0.48% |
+70,699
| New | +$26.3M |
|
53
Biogen
BIIB
$30.7B
| $25.4M | 0.47% |
73,457
+55,981
| +320% | +$17M |
|
54
MarketWise
MKTW
$53.1M
| $24.8M | 0.46% |
124,662
| – | – |
|
55
Alkermes
ALKS
$8.39B
| $24.5M | 0.46% |
997,950
+126,390
| +15% | +$2.81M |
|
56
Cirrus Logic
CRUS
$6.65B
| $24.4M | 0.46% |
286,737
-122,066
| -30% | -$9.79M |
|
57
Synopsys
SNPS
$71.3B
| $24.1M | 0.45% |
87,263
-1,345
| -2% | -$341K |
|
|
OLK
58
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $23.8M | 0.44% |
690,908
+15,784
| +2% | +$542K |
|
59
Amgen
AMGN
$209B
| $23M | 0.43% |
94,408
+10,047
| +12% | +$2.47M |
|
60
Pfizer
PFE
$142B
| $22.9M | 0.43% |
584,101
+27,026
| +5% | +$1.05M |
|
61
Baidu
BIDU
$36.5B
| $22.8M | 0.43% |
112,027
+65,788
| +142% | +$13.2M |
|
62
Edgewell Personal Care
EPC
$1.26B
| $22.7M | 0.42% |
517,348
+88,427
| +21% | +$3.75M |
|
|
P
63
Everpure Inc
P
$25B
| $22.3M | 0.42% |
+1,143,151
| New | +$22.5M |
|
64
Vor Biopharma
VOR
$1.18B
| $21.4M | 0.4% |
57,325
-338
| -0.6% | -$167K |
|
|
CCC
65
CCC Intelligent Solutions
CCC
$3.57B
| $21.3M | 0.4% |
2,134,599
-195,025
| -8% | -$1.97M |
|
66
Playtika
PLTK
$1.51B
| $20.9M | 0.39% |
877,619
| – | – |
|
67
Senti Biosciences Holdings
SNTI
$11.2M
| $19.9M | 0.37% |
+200,000
| New | +$20M |
|
68
Aurora
AUR
$12.2B
| $19.8M | 0.37% |
+2,000,000
| New | +$19.8M |
|
69
F5
FFIV
$22.1B
| $19.7M | 0.37% |
+105,575
| New | +$20.3M |
|
70
Aldeyra Therapeutics
ALDX
$96.5M
| $19.4M | 0.36% |
1,708,923
+978,529
| +134% | +$11.8M |
|
|
JNPR
71
DELISTED
Juniper Networks
JNPR
| $19M | 0.35% |
694,255
+256,928
| +59% | +$6.84M |
|
72
Charter Communications
CHTR
$16.9B
| $18.9M | 0.35% |
26,218
+13,972
| +114% | +$9.41M |
|
73
Maravai LifeSciences
MRVI
$996M
| $18.9M | 0.35% |
452,944
-61,013
| -12% | -$2.36M |
|
|
LSXMA
74
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $18.6M | 0.35% |
+542,331
| New | +$17.8M |
|
75
Semtech
SMTC
$10.7B
| $18.5M | 0.34% |
268,237
+62,914
| +31% | +$4.16M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.
- Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
- Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
- Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
- Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
- Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
- Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
- Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.
Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.